Showing 771-780 of 2378 results for "".
Noninflammatory Myopathies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/noninflammatory-myopathies/31557/As genetic diagnosis increases, noninflammatory myopathies are being seen more in clinical practice.Pediatric Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/pediatric-traumatic-brain-injury/31985/Assessment, acute care treatment, and rehabilitation and recoveryThe Myth of Medical Gaslighting: When Patient Perception and Physician Intention Collide
https://practicalneurology.com/columns/practice-management/the-myth-of-medical-gaslighting-when-patient-perception-and-physician-intention-collide/36117/Open and frank communication with patients, especially those considered challenging, has a dual benefit: minimizing errors and improving patient trust.Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: Current Landscape and Potential Utility in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/blood-and-cerebrospinal-fluid-biomarkers-in-amyotrophic-lateral-sclerosis-current-landscape-and-potential-utility-in-clinical-practice/35542/Amyotrophic lateral sclerosis biomarkers are increasingly shaping the development of new treatments.Pharmacologic Management of Behavioral Challenges and Psychiatric Comorbidities in People With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacologic-management-of-behavioral-challenges-and-psychiatric-comorbidities-in-people-with-epilepsy/39969/Treatment of behavioral and psychiatric comorbidities in people with epilepsy requires careful consideration of underlying causes, symptom profile, antiseizure medications, and epilepsy type.Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.The Prognostic Utility of Neurofilament Light Chain in Multiple Sclerosis: A Narrative Review
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-prognostic-utility-of-neurofilament-light-chain-in-multiple-sclerosis-a-narrative-review/32098/Neurofilament light chain has great promise as a prognostic biomarker in multiple sclerosis.Managing Mood Disorders, Behavioral Changes, and Psychosis in People Living with Vascular Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/managing-mood-disorders-behavioral-changes-and-psychosis-in-people-living-with-vascular-dementia/36649/This article explores the neuropsychiatric symptoms associated with vascular dementia, including their underlying mechanisms, clinical implications, and potential management strategies.Antiplatelet Therapies After Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/antiplatelet-therapies-after-ischemic-stroke/31862/Antiplatelet therapies are effective for prevention of secondary stroke and can be tailored to individual patient needs.Managing Symptoms of Depression, Apathy, Psychosis, and Agitation in People Living with Alzheimer Disease
https://practicalneurology.com/archives/aug-2025-issue/managing-symptoms-of-depression-apathy-psychosis-and-agitation-in-people-living-with-alzheimer-disease/36689/Optimal treatment of neuropsychiatric symptoms in Alzheimer disease necessitates early identification, rigorous clinical differentiation, and the development of individualized therapeutic approaches.